Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Inova Health Care Services
With
National Institutes of Health (NIH)
Duke University
George Mason University
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI)
Patients who are enrolling in the TRANSFORM-HF study or being prescribed Torsemide or Furosemide at hospital discharge will provide blood and urine at the time of study enrollment (within 72 hours of hospital discharge) and at 90 days (+/- one week) after hospital discharge.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participation in the TRANSFORM-HF trial or prescription of Torsemide or Furosemide
Willing to provide blood and urine sample at enrollment and follow-up
You may not be if
Inability or unwillingness to comply with the study requirements
Clareo Health | TRANSFORM-HF Ancillary Mechanistic Study
